Important Resources for Professionals

Gluxus team of professionals continue to research and provide most current and official resources for multi-disciplinary diabetes healthcare providers and researchers, including practical applications for professional education and research, as well as references to inform and guide best practices for the care of people with diabetes.
We want you to join us in raising awareness by providing us feedback on the usefulness of the information captured here. We are also looking forward to partnering with you to capture here the best diabetes information available to date so that together we can build a global village of support for peers and experts alike.
Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can lead to complications such as heart disease, stroke, kidney disease, blindness, nerve damage, gum infections, and peripheral vascular disease.
Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT), and an A1C of 5.7-6.4% are included in a category of increased risk for future diabetes (also known as pre-diabetes). This is defined as blood glucose or A1C levels higher than normal but not high enough to be characterized as diabetes. People with IFG, IGT, and an increase A1C are at risk for developing type 2 diabetes and also have an increase risk of heart disease and stroke. With modest weight loss and moderate physical activity, people with pre-diabetes can delay or prevent type 2 diabetes.

New recommendations by American Diabetes Association (ADA)

define A1C testing as an appropriate test for diagnosing diabetes when A1C is greater than or equal to 6.5%. Diagnosis should be confirmed by a repeat A1C test unless clinical symptoms and glucose levels over 200 mg/dL are present.

A1C testing may not be reliable due to patient factors which preclude its interpretation (e.g. any anemia, hemoglobinopathy or abnormal erythrocyte turnover). In this case previously recommended diagnostic measures should be used (fasting plasma glucose and 2 hour oral glucose tolerance test).
<strong>Clinical Practice Guidelines</strong>
Clinical Practice Guidelines
Best Clinical Practice Guidelines as provided by diabetes organizations in Canada and the USA for the prevention and management of diabetes. more…
<strong>Recent Approvals and Recalls</strong>
Recent Approvals and Recalls
Latest information about Diabetes Insulin and Diagnostics Device Approvals and Recalls (A&R) is provided for  reference. more…
<strong>Important Publications</strong>
Important Publications
A list of important publications published by both Canadian and USA official diabetes organizations is found here. more…

Latest myGluxus Diabetes Blog

  • Type I Diabetes: You are NOT alone. General Diabetes Statistics
  • July 9th, 2018

Diabetes is a serious, chronic condition that occurs either when the pancreas does not produce enough insulin (a hormone […]

  • Juvenile Diabetes: Coping with it
  • June 14th, 2018

Living with type 1 diabetes can be emotionally draining. It’s normal for people with type 1 diabetes to feel […]

  • Juvenile Diabetes: Dealing with Feelings

For anyone with diabetes, experiencing negative emotions such as anger, frustration, hopelessness, fear, guilt and shame is very common. […]

  • Treatments for Juvenile Diabetes

If your child or teen has been diagnosed with type 1 diabetes, the next step is to create a […]